Melanotan II: The Tanning Peptide and Its Documented Problems

Melanotan II is a synthetic analogue of alpha-melanocyte-stimulating hormone, used to produce skin darkening without sun exposure. It is not approved in the US, EU, UK, or Australia, and several regulators have issued warnings about it specifically.

It is unusual in this category for a reason worth stating plainly: because it has been widely used, there is an accumulating case-report literature describing what happens to people who take it. Most research peptides have no human record at all.

How it works

Alpha-MSH binds melanocortin receptors, and the MC1R subtype drives melanin production. Melanotan II is a non-selective melanocortin agonist — it activates MC1R, producing pigmentation, but also other receptors in the family.

That non-selectivity is the source of most of its effects beyond tanning. Its relationship to PT-141 is direct: bremelanotide is a metabolite of melanotan II, developed specifically for the sexual-response effect that appeared as a side effect of the tanning compound.

The contrast with KPV is the other half of the story. Both come from alpha-MSH; KPV discards the pigmentation activity, melanotan II is built around it.

Documented effects

The case-report and pharmacovigilance literature consistently describes:

• Nausea and flushing, commonly reported and often dose-related.

• Spontaneous erections, reflecting the melanocortin activity that later became PT-141.

• Darkening of existing moles and appearance of new pigmented lesions.

• Pigmentation of mucosa, including oral mucosal changes described in the case literature.

• Systemic effects including reported blood pressure and appetite changes.

Why the supply is a separate problem

Melanotan II sits entirely outside any regulated supply chain. There is no manufacturer accountable for identity, purity, sterility, or content, and no adverse-event reporting system.

The guide to reading a certificate of analysis covers what can and cannot be verified about such material, and are peptides legal covers why "research use only" is a statement about marketing rather than quality.

Melanotan I and II

Melanotan I (afamelanotide) is a different molecule with a genuine regulatory history — it has been approved in some jurisdictions for a specific rare photosensitivity condition, under specialist supervision. Melanotan II has no such status anywhere.

The names are similar enough that they are frequently conflated, including by sellers. They are not interchangeable and their regulatory positions are not comparable.

Frequently asked questions

Is melanotan II legal?

It is not an approved medicine in any major jurisdiction, and several regulators have issued specific warnings. See are peptides legal for why that question has several separate answers.

Does it cause melanoma?

Causation is not established. What is documented is that it darkens moles and is associated with new pigmented lesions, which interferes with the visual changes melanoma screening depends on. That is a concrete problem independent of whether it causes cancer.

Why is there no dosing chart here?

Because this is an unapproved compound with documented adverse effects and no established safe dose, and a chart would imply a level of confidence that does not exist.